Oxolinic acid OA 2 µg

by Liofilchem S.r.l. Italy EUDAMED

Ref 9002

EMDN W0104080502

Regulatory status

as of 24 Oct 2026

Region	Authorization	Number	Date	Status
European Union	CE/IVDD	NumberB-18055182874535 Basic UDI-DI	Date21 Oct 2026Registered	StatusActive

Coverage

1 jurisdiction

Expiring (legacy directive)
Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name: Oxolinic acid OA 2 µg
Model / Reference: 9002

Primary DI / UDI-DI: 18055182874535
Basic UDI-DI: B-18055182874535
EMDN Code: W0104080502 Impregnated disks, multi-disks & tablets

Device Class: Class IVD General
Market of Registration: Italy

Manufacturer details

EUDAMED SRN: IT-MF-000026495

Other devices from Liofilchem S.r.l.

Trimethoprim-sulfamethoxazole (1.25+23.75) SXT 25 µg

Class B
Tetracycline TE 30 µg

Class B
Gentamicin CN 0.016-256

Class B
Erythromycin E 15 µg

Class B
Nitrofurantoin F 100 µg

Class B
Cefepime-enmetazobactam (30+20) FPE 50 µg

Class B

See all devices from Liofilchem S.r.l. →

Properties & raw data

Show properties, registry sources and raw records

Animal Tissues
Professional Testing

Other properties (8)

Sterile: No
Human Tissues: No
Microbial Substances: No
Reagent: No
Self Testing: No
Near-Patient Testing: No
Companion Diagnostics: No
Surgical Instrument: No

Sources (1)

EUDAMED 18055182874535|B-18055182874535 61 fields · synced 24 Oct 2026